ClinicalTrials.gg
Sign In

Mucocutaneous Lymph Node Syndrome clinical trials

The registry lists 62 studies for Mucocutaneous Lymph Node Syndrome across more than 10 countries. 17 are recruiting or about to start. 54 of them are mainly about Mucocutaneous Lymph Node Syndrome (how this is decided). Per ClinicalTrials.gov, last updated 2026-10-28.

Get an email when these change. Save the Mucocutaneous Lymph Node Syndrome studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
28
Recruiting
11
Status unknown
11
Not yet recruiting
4
Withdrawn
4
Enrolling by invitation
2

Phase

Phase 3
13
Phase 2
12
Phase 4
5
Phase 1
5
Early Phase 1
1

Where

United States
18
China
16
Taiwan
8
France
6
Italy
4
Canada
4

Who runs them

Children's Hospital of Fudan University (11) · University of California, San Diego (8) · National Taiwan University Hospital (4) · Meyer Children's Hospital IRCCS (3) · Chang Gung Memorial Hospital (3) · Assistance Publique - Hôpitaux de Paris (2) · West China Second University Hospital (2) · Lantheus Medical Imaging (2)

What is being tested here

Drugs under test in Mucocutaneous Lymph Node Syndrome studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Rivaroxaban202
Interleukin 1 Receptor Antagonist Protein115
Firsekibart111
Infliximab056
Immunoglobulin G034
Atorvastatin003
Immunoglobulins, Intravenous033
Prednisolone022
Aspirin002
Doxycycline001

Drug classes tested here Statins 4 · Corticosteroids 3

Coming up

3phase 3 studies under way
7studies finish main data collection within a year3 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 7, phase 3 first

Who these studies take

Of the 11 Mucocutaneous Lymph Node Syndrome studies recruiting now, 1 (9%) set no upper age limit and 10 (91%) stop at 75 or younger. 11 (100%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 1 (9%) take healthy volunteers.

Recruiting studies that take each age, of 11
AgeWomenMen
1011 (100%)11 (100%)
188 (73%)8 (73%)
301 (9%)1 (9%)
401 (9%)1 (9%)
501 (9%)1 (9%)
651 (9%)1 (9%)
751 (9%)1 (9%)
851 (9%)1 (9%)

Across all 62 studies, recruiting or not: 85% stop at 75 or younger and 85% at 65; 95% take children; 0% are for women only and 0% for men only; 19% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

What changed recently

From the registry's own updates since Oct 13, 2026.

Stopped1

Studies

Recruiting first, then most recently updated. Showing 50 of 62. Browse all 62 → or search them.